HB 652; 2R - Right to Try Act for Terminally Ill Patients

Allows patients diagnosed with a terminal illness to try investigational drugs, biological product or medical device. Investigational means one that has passed Phase I of an USFDA clinical trial and remains under investigation in an approved clinical trial. Civitas believes the conservative position is to allow for more freedom of choice in the healthcare industry. The conservative vote is yes.